SEBIO 2016 Board of Directors

Officers:
Chair: Sue Washer, AGTC
Vice-Chair and Secretary: Todd Sherer, Emory University, Office of Technology Transfer
Treasurer: Mark Baxter, Ernst & Young
Ex Officio: Becky Kaufman, King & Spalding, LLP

Executive Committee:
Mark Baxter, Ernst & Young
Becky Kaufman, King & Spalding LLP
Todd Sherer, Ph.D., Emory University, Office of Technology Transfer
Sue Washer, AGTC
Dave Winwood, Pennington Biomedical Research Center

Directors:
Brian Adams, Ph.D., Arbor Pharmaceuticals, Inc.
Russell Allen, Georgia Bio
Ali Behbahani, NEA
William Brooke, Harbert Ventures Partners
Gerry Brunk, Lumira Capital
Nancy Bryan, BioFlorida
Tom Callaway, M.D., HealthQuest Capital
Suzanne Cantando, Southeast BIO
Jill Carroll, SR One
David L. Day, University of Florida, Office of Technology Licensing
Jeff Gallagher, Virginia Biotechnology Association
Tim Gupton, Hughes Pittman & Gupton, LLP
Mike Gutch, Ph.D., AstraZeneca
Steve Hall, Lilly Ventures
H. Lee Herron, DVM, Georgia Research Alliance
Frank Hunt, PNP Therapeutics, Inc.
Mara Huntington, Square 1 Bank
Garheng Kong, HealthQuest Capital
Sharon Krueger, University of Virginia, Office of the VP for Research
Scott McCarty, Silicon Valley Bank
Tina McKeon, Kilpatrick Townsend & Stockton, LLP
Kathy Nugent, PhD, BioAlabama
Jim O’Connell, University of Miami, Office of Technology Transfer
Dan O’Korn, Hutchison Law Group, PLLC
David Pierson, Syngenta Crop Protection
Doug Reed, Hatteras Venture Partners
Larry Robbins, Wyrick Robbins Yates & Ponton, LLP
Wayne Roper, SCBIO
James Rosen, Bill & Melinda Gates Foundation
Ken Tindall, Ph.D., North Carolina Biotechnology Center
Abby Trotter, Life Science Tennessee
Geeta Vemuri, Baxalta
Miriam Wilson, Council for Entrepreneurial Development (CED)
Ford Worthy, Pappas Ventures
Karen Zederej, AxoGen, Inc.